(August 2, 2012) -- Christmas came early this year for the FTC, when on July 16 the Third Circuit became the first court to accept the agency’s view that pay-for-delay settlements between patent-holding pharmaceutical companies and generic entrants are presumptively anticompetitive. The case may now be headed for the Supreme Court, as the ruling creates a split among the circuits on a big-bucks issue....